INSIDER
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProMethodologyMatch reviewLaunch readiness
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProMethodologyMatch reviewLaunch readiness
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 424m ago
HOUSE PTR24m ago
SEC 13F24m ago
ROBINHOOD CHAIN23m ago
Corporate insider
TR

Thakkar Roopal

EVP, R&D and CSOCIK 0002004979

EDGAR filingsOpen in network
Disclosed transactions5
Buys / sells0 / 0
Max Insider Score13
Connections1with evidence

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
13
TR
Thakkar RoopalEVP, R&D and CSO
ABBVAbbVie Inc.
Grant or award
A—
6,015 sh
Feb 18, 2026Feb 20, 2026
traded Feb 18, 2026
+2dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    AbbVie Inc.EVP, R&D and CSO · Feb 20, 2026
9
TR
Thakkar RoopalEVP, R&D and CSO
ABBVAbbVie Inc.
Grant or award
A
—
2,138 sh
Feb 18, 2026
Feb 20, 2026
traded Feb 18, 2026
+2d
SEC FORM 4

Evidence

13
TR
Thakkar RoopalEVP, R&D and CSO
ABBVAbbVie Inc.
Grant or award
A—
3,346 sh
Feb 18, 2026Feb 20, 2026
traded Feb 18, 2026
+2dSEC FORM 4

Evidence

13
TR
Thakkar RoopalEVP, R&D and CSO
ABBVAbbVie Inc.
Grant or award
A—
6,638 sh
Feb 18, 2026Feb 20, 2026
traded Feb 18, 2026
+2dSEC FORM 4

Evidence

9
TR
Thakkar RoopalEVP, R&D and CSO
ABBVAbbVie Inc.
Grant or award
A—
21.9K sh
Feb 18, 2026Feb 20, 2026
traded Feb 18, 2026
+2dSEC FORM 4

Evidence